Invention Grant
US08575094B2 Use of type-B lantibiotic-based compounds having antimicrobial activity
失效
使用具有抗微生物活性的B型蓝色素抗生素类化合物
- Patent Title: Use of type-B lantibiotic-based compounds having antimicrobial activity
- Patent Title (中): 使用具有抗微生物活性的B型蓝色素抗生素类化合物
-
Application No.: US12357077Application Date: 2009-01-21
-
Publication No.: US08575094B2Publication Date: 2013-11-05
- Inventor: Sjoerd Nicolaas Wadman , Michael John Dawson , Jesus Cortes Bargallo
- Applicant: Sjoerd Nicolaas Wadman , Michael John Dawson , Jesus Cortes Bargallo
- Applicant Address: GB Hertfordshire
- Assignee: Novacta Biosystems Limited
- Current Assignee: Novacta Biosystems Limited
- Current Assignee Address: GB Hertfordshire
- Agency: Morgan, Lewis & Bockius LLP
- Priority: GB0714030.4 20070718
- Main IPC: A61K38/12
- IPC: A61K38/12 ; C07K7/64
Abstract:
A method for the treatment or prophylaxis of a microbial infection of the lower intestine or colon in a subject is described, wherein the method comprises administration to the subject of a type-B lantibiotic, wherein the type-B lantibiotic may include compounds selected from the group consisting of mersacidin, actagardine, plantaricin, planosporicin, ruminococcin, antibiotic 10789, michiganin and haloduracin, and derivatives and variants thereof.
Public/Granted literature
- US08183202B2 Use of type-B lantibiotic-based compounds having antimicrobial activity Public/Granted day:2012-05-22
Information query
IPC分类:
